>
Lexagene Holdings Inc logo

LXG - Lexagene Holdings Inc Share Price

C$0.59 -0.0  -3.3%

Last Trade - 07/05/21

Sector
Healthcare
Size
Micro Cap
Market Cap £41.3m
Enterprise Value £35.9m
Revenue £n/a
Position in Universe 1020th / 2702
Bullish
Bearish
Unlock LXG Revenue
Momentum
Relative Strength (%)
1m -25.6%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -61.7%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 29th Feb 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
0.000 0.000 0.000 0.000 0.000 0.000 2.78 13.3
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the nine months ended 30 November 2020, LexageneHoldings Inc revenues was not reported. Net loss increased29% to $7.5M. Higher net loss reflects Research anddevelopment - Balancing val increase from $890K to $2M(expense), Salaries increase of 30% to $2.4M (expense),Salaries increase from $385K to $853K (expense). BasicEarnings per Share excluding Extraordinary Items increasedfrom -$0.08 to -$0.07.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

LXG Revenue Unlock LXG Revenue

Net Income

LXG Net Income Unlock LXG Revenue

Normalised EPS

LXG Normalised EPS Unlock LXG Revenue

PE Ratio Range

LXG PE Ratio Range Unlock LXG Revenue

Dividend Yield Range

LXG Dividend Yield Range Unlock LXG Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
LXG EPS Forecasts Unlock LXG Revenue
Profile Summary

LexaGene Holdings, Inc. is a Canada-based molecular diagnostics company. The Company develops genetic analyzers for pathogen detection and other molecular markers for on-site testing in veterinary diagnostics, food safety and for use in open-access markets, including clinical research, agricultural testing and biodefense. It offers MiQLab genetic analyzer. The MiQLab genetic analyzer offers automated pathogen detection and customized testing. The MiQLab genetic analyzer draws each liquid sample into a sample preparation cartridge, where microbes are concentrated and lysed before the genetic material is purified. Its analyzer pulls the purified genomic material from inside the cartridge into the system’s microfluidics where a series of real-time polymerase chain reaction (PCR) mixtures are assembled, multiplex quantitative polymerase chain reactions (qPCR) are amplified and the results are analyzed.

Directors
Last Annual February 29th, 2020
Last Interim November 30th, 2020
Incorporated April 26, 2007
Public Since August 28, 2007
No. of Shareholders: n/a
No. of Employees: 22
Sector Healthcare
Industry Biotechnology & Medical Research
Index
Exchange TSX Venture Exchange
Shares in Issue 118,694,759
Free Float (0.0%)
Eligible for
ISAs
SIPPs
LXG Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for LXG
Upcoming Events for LXG
Frequently Asked Questions for Lexagene Holdings Inc
What is the Lexagene Holdings Inc share price?

As of 07/05/21, shares in Lexagene Holdings Inc are trading at C$0.59, giving the company a market capitalisation of £41.3m. This share price information is delayed by 15 minutes.

How has the Lexagene Holdings Inc share price performed this year?

Shares in Lexagene Holdings Inc are currently trading at C$0.59 and the price has moved by -24.36% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Lexagene Holdings Inc price has moved by -41.32% over the past year.

What are the analyst and broker recommendations for Lexagene Holdings Inc?

There are no analysts currently covering Lexagene Holdings Inc.

When will Lexagene Holdings Inc next release its financial results?

Lexagene Holdings Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-11-30
What is the Lexagene Holdings Inc dividend yield?

Lexagene Holdings Inc does not currently pay a dividend.

Does Lexagene Holdings Inc pay a dividend?

Lexagene Holdings Inc does not currently pay a dividend.

When does Lexagene Holdings Inc next pay dividends?

Lexagene Holdings Inc does not currently pay a dividend.

How do I buy Lexagene Holdings Inc shares?

To buy shares in Lexagene Holdings Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Lexagene Holdings Inc?

Shares in Lexagene Holdings Inc are currently trading at C$0.59, giving the company a market capitalisation of £41.3m.

Where are Lexagene Holdings Inc shares listed? Where are Lexagene Holdings Inc shares listed?

Here are the trading details for Lexagene Holdings Inc:

Country of listing: Canada
Exchange: CVE
Ticker Symbol: LXG
What kind of share is Lexagene Holdings Inc?

Based on an overall assessment of its quality, value and momentum, Lexagene Holdings Inc is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Lexagene Holdings Inc share price forecast 2021?

Shares in Lexagene Holdings Inc are currently priced at C$0.59. At that level they are trading at 0.219% discount to the analyst consensus target price of 0.00.

Analysts covering Lexagene Holdings Inc currently have a consensus Earnings Per Share (EPS) forecast of -0.0403957131 for the next financial year.

How can I tell whether the Lexagene Holdings Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Lexagene Holdings Inc. Over the past six months, the relative strength of its shares against the market has been -23.65%. At the current price of C$0.59, shares in Lexagene Holdings Inc are trading at -33.62% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Lexagene Holdings Inc PE Ratio?

We were not able to find PE ratio data for Lexagene Holdings Inc.

Who are the key directors of Lexagene Holdings Inc?

Lexagene Holdings Inc's management team is headed by:

Daryl Rebeck - PRE
John Regan - CHM
Tom Slezak - IND
Manohar Furtado - IND
Jeffrey Mitchell - CFO
Joseph Caruso - IND
Steven Armstrong - SDR
Eleanor Kolossovski - DMK
Stephen Mastrocola - DRC
Who are the major shareholders of Lexagene Holdings Inc?

Here are the top five shareholders of Lexagene Holdings Inc based on the size of their shareholding:

Regan (John F) Individual Investor
Percentage owned: 5.19% (6.17m shares)
Rebeck (Daryl) Individual Investor
Percentage owned: 4.81% (5.70m shares)
Caruso (Joseph P) Individual Investor
Percentage owned: 0.23% (270k shares)
Furtado (Manohar Rajeev Ph.D.) Individual Investor
Percentage owned: 0.18% (212k shares)
Spartan Fund Management Inc. Investment Advisor
Percentage owned: 0.12% (141k shares)
Similar to LXG
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.